Evidence map›Paper›PMID 24019897›Full record

ArticlePloS one2013

Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells.

Saurabh Trikha, Aleksandar M Jeremic

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Amyloid Beta Is InternalizedFrontiers in molecular neuroscience · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal CaBiochimica et biophysica acta. Molecular basis of disease · 2018
    Article
  14. Review
  15. Article
  16. The Molecular Physiopathogenesis of Islet Amyloidosis.Handbook of experimental pharmacology · 2018
    Review
  17. Review
  18. Article
  19. Amylin alters human brain pericyte viability and NG2 expression.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saurabh TrikhaDepartment of Biological Sciences, The George Washington University, Washington, District of Columbia, United States of America.
Aleksandar M Jeremic
George Washington University · US

Funding

Molecular Mechanisims of Amylin Trafficking and Toxicity in Human Pancreatic IsleR01DK091845 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JEREMIC, ALEKSANDAR MILORAD · 2013 to 2017
$1.4M
NIDDK NIH HHS R01 DK091845NIDDK NIH HHS R01-DK091845
6 · The paper itself

Abstract

Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes mellitus (TTDM). Although recent studies have shown that pancreatic cells can recycle amylin monomers and toxic oligomers, the exact uptake mechanism and trafficking routes of these molecular forms and their significance for amylin toxicity are yet to be determined. Using pancreatic rat insulinoma (RIN-m5F) beta (β)-cells and human islets as model systems we show that monomers and oligomers cross the plasma membrane (PM) through both endocytotic and non-endocytotic (translocation) mechanisms, the predominance of which is dependent on amylin concentrations and incubation times. At low (≤ 100 nM) concentrations, internalization of amylin monomers in pancreatic cells is completely blocked by the selective amylin-receptor (AM-R) antagonist, AC-187, indicating an AM-R dependent mechanism. In contrast at cytotoxic (µM) concentrations monomers initially (1 hour) enter pancreatic cells by two distinct mechanisms: translocation and macropinocytosis. However, during the late stage (24 hours) monomers internalize by a clathrin-dependent but AM-R and macropinocytotic independent pathway. Like monomers a small fraction of the oligomers initially enter cells by a non-endocytotic mechanism. In contrast a majority of the oligomers at both early (1 hour) and late times (24 hours) traffic with a fluid-phase marker, dextran, to the same endocytotic compartments, the uptake of which is blocked by potent macropinocytotic inhibitors. This led to a significant increase in extra-cellular PM accumulation, in turn potentiating amylin toxicity in pancreatic cells. Our studies suggest that macropinocytosis is a major but not the only clearance mechanism for both amylin's molecular forms, thereby serving a cyto-protective role in these cells.

Indexed as

EndocytosisAnimalsBiopolymersCell Line, TumorCells, CulturedHumansIslet Amyloid PolypeptideMicroscopy, ConfocalPancreasRatsReceptors, Islet Amyloid PolypeptideBiopolymersIslet Amyloid PolypeptideReceptors, Islet Amyloid Polypeptide

Identifiers

PMID24019897
PMCPMC3760900
OpenAlexW2116357754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.